Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Jesse L. Cramer PharmD

Jesse L. Cramer PharmD profile photo picture

Adjunct Assistant Professor

Institution: Medical College of Wisconsin
Department: School of Pharmacy Administration
Division: Administration
Program: Program Development

image of /images/ORCIDiD_icon16x16.png   https://orcid.org/0000-0003-3136-7780

View Curriculum Vitae

Clinical Expertise

  • Drug Compounding
  • Faculty
  • Intensive Care Units, Pediatric
  • Pediatrics
  • Pharmacists
  • Pharmacy
  • Pharmacy and Therapeutics Committee

    • Leadership Positions

  • Pharmacist lead Alaris Interoperability Workgroup
  • Manager, Clinical Pharmacy Services

    • MCW Program / Core Facilities

  • pharm

    • Publications (10)

  • Navigating clinical and operational challenges of adeno-associated virus gene therapy: A guide for pharmacists (Riedy M, Pan I, Cramer J, Garrity L) Jaccp Journal of the American College of Clinical Pharmacy June 2025;8(6):469-480 SCOPUS ID: 2-s2.0-105003814179 06/01/2025    
  • When parenteral nutrition is the answer: The case of pediatric intestinal rehabilitation (Kaenkumchorn TK, Lampone O, Huebner K, Cramer J, Karls C) Nutrition in Clinical Practice October 2024;39(5):991-1002 SCOPUS ID: 2-s2.0-85197412883 10/01/2024    
  • When parenteral nutrition is the answer: The case of pediatric intestinal rehabilitation. (Kaenkumchorn TK, Lampone O, Huebner K, Cramer J, Karls C) Nutr Clin Pract 2024 Oct;39(5):991-1002 PMID: 38961658 SCOPUS ID: 2-s2.0-85197412883 07/04/2024    
  • Evaluation of potential cost savings through chemotherapy and biotherapy dose-rounding at a pediatric institution (Graff JM, Cramer J, Kolb LL, Agherrabi Z, Burgess M) Journal of Oncology Pharmacy Practice June 2024;30(4):705-709 SCOPUS ID: 2-s2.0-85162695295 06/01/2024       1 Citation
  • Clinical course and therapeutic trial for a case of congenital secretory diarrhea due to novel GUCY2C variant. (Scott W, Wong IGY, Cramer J, Horton D, Basel D, Teng RJ, Muriello M, Elkadri A) Am J Med Genet A 2024 Apr;194(4):e63489 PMID: 38058249 SCOPUS ID: 2-s2.0-85178961963 12/07/2023    
  • Evaluation of potential cost savings through chemotherapy and biotherapy dose-rounding at a pediatric institution. (Graff JM, Cramer J, Kolb LL, Agherrabi Z, Burgess M) J Oncol Pharm Pract 2024 Jun;30(4):705-709 PMID: 37350075 SCOPUS ID: 2-s2.0-85162695295 06/23/2023       1 Citation
  • Tolerability and Efficacy of a 1-Bag Pegaspargase Densensitization Protocol in Pediatric Oncology Patients. (Cramer J, Graff J, Serebin D) J Pediatr Hematol Oncol 2022 Apr 01;44(3):e623-e627 PMID: 34133383 SCOPUS ID: 2-s2.0-85127925439 06/17/2021       5 Citations
  • Stability Determination of an Extemporaneously Compounded Ambrisentan Suspension by High Performance Liquid Chromatography Analysis. (Cramer J, Bevry M, Handler S, Tillman K, Abourashed EA) J Pediatr Pharmacol Ther 2021;26(3):265-270 PMID: 33833628 PMCID: PMC8021248 SCOPUS ID: 2-s2.0-85104684194 04/10/2021       1 Citation
  • Safety of Continuous Neostigmine for the Treatment of Impaired Gastrointestinal Motility in Pediatric Patients. (Cramer J, Pabian I) Ann Pharmacother 2021 Feb;55(2):267-268 PMID: 32627563 SCOPUS ID: 2-s2.0-85087445044 07/07/2020    
  • Comparison of Morphine- and Hydromorphone-Containing Patient-Controlled Epidural Analgesia Solutions in Pediatric Postoperative Patients. (Cramer J) J Pediatr Pharmacol Ther 2019;24(1):22-26 PMID: 30837810 PMCID: PMC6397006 SCOPUS ID: 2-s2.0-85070208504 03/07/2019       3 Citations
    • Last update: 05/10/2025